Carl Zeiss Meditec AG Financials

Market Capitalization €4.56 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	25.92
Forward PE	21.44
Price to Sales TTM	€2.21
Price to Book MRQ	€2.23
Enterprise to Revenue	2.44
Enterprise to EBITDA	17.13

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-09-30
Most Recent Quarter	2024-09-30
Profit Margin	9.83%
Operating Margin	10.14%
Return on Assets TTM	5.27%
Return on Equity TTM	8.69%

Income Statement

Revenue TTM	€2,066,200,064
Revenue per Share TTM	€23.14
Quarterly Revenue Growth	0.80%
Gross Profit TTM	€1,138,765,056
EBITDA	€250,774,000
Net Income to Common TTM	€203,196,000
Diluted EPS TTM	€2.01
Quarterly Earnings Growth YoY	-63.00%

Balance Sheet

Total Cash MRQ	€15,339,000
Total Cash per Share MRQ	€0.17
Total Debt MRQ	€
Total Debt to Equity MRQ	6.74
Current Ratio MRQ	2.13
Book Value per Share MRQ	€23.42

Cash Flow

Operating Cash Flow TTM	€237,331,000
Levered Free Cash Flow TTM	€178,726,000

AFX Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	87,536,096
Float Shares	36,691,748
Avg 10 Volume	243
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	59.14%
% Held by Institutions	24.51%

Stock Price Summary

Beta	1.04
Fifty Two Week Low	€44.44
Fifty Two Week High	€123.00
Fifty Two Week Change	-80.41%
Day 50 MA	€51.28
Day 200 MA	€66.28

Dividends and Splits

Forward Annual Dividend Rate	€4.40
Forward Annual Dividend Yield	7.87%
Trailing Annual Dividend Rate	€1.10
Trailing Annual Dividend Yield	1.97%
Payout Ratio	48.25%
Dividend Date
Ex Dividend Date	2024-03-22
Last Split Factor
Last Split Date